Facephi Biometria SA (8FB) Ratios
Facephi Biometria SA Ratios
DE:8FB's free cash flow for Q4 2025 was $-1.87M. For the 2025 fiscal year, DE:8FB's free cash flow was decreased by $-8.63M and operating cash flow was $6.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 1.08 | 0.85 | 1.24 | 2.33 |
| Quick Ratio | 1.12 | 1.08 | 0.85 | 1.24 | 2.33 |
| Cash Ratio | 0.08 | 0.20 | 0.12 | 0.15 | 0.30 |
| Solvency Ratio | 0.27 | -0.11 | -0.14 | 0.18 | 0.08 |
| Operating Cash Flow Ratio | 0.29 | 0.03 | 0.04 | -0.46 | -0.80 |
| Short-Term Operating Cash Flow Coverage | 1.06 | 0.08 | 0.09 | -1.48 | -3.05 |
| Net Current Asset Value | $ 1.85M | $ -1.44M | $ -6.56M | $ -1.16M | $ 827.25K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.20 | 0.28 | 0.24 | 0.34 |
| Debt-to-Equity Ratio | 0.33 | 0.53 | 0.65 | 0.51 | 0.71 |
| Debt-to-Capital Ratio | 0.25 | 0.35 | 0.39 | 0.34 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.05 | 0.13 | 0.19 | 0.37 |
| Financial Leverage Ratio | 2.20 | 2.59 | 2.28 | 2.12 | 2.11 |
| Debt Service Coverage Ratio | 1.02 | -0.17 | -0.18 | 0.80 | 0.71 |
| Interest Coverage Ratio | 4.31 | -4.38 | -3.15 | 5.82 | -1.54 |
| Debt to Market Cap | 0.11 | 0.25 | 0.30 | 0.18 | 0.11 |
| Interest Debt Per Share | 0.30 | 0.48 | 0.69 | 0.47 | 0.44 |
| Net Debt to EBITDA | 0.67 | -21.16 | -2.14 | 1.80 | 5.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.22% | 45.74% | 88.32% | 102.84% | 102.26% |
| EBIT Margin | 3.11% | -20.12% | -18.51% | 5.95% | -3.52% |
| EBITDA Margin | 21.95% | -0.76% | -16.28% | 14.81% | 6.24% |
| Operating Profit Margin | 10.08% | -23.10% | -18.36% | 7.84% | -4.57% |
| Pretax Profit Margin | 0.77% | -25.39% | -24.06% | 4.60% | -6.48% |
| Net Profit Margin | 1.02% | -30.77% | -14.70% | 4.97% | -4.21% |
| Continuous Operations Profit Margin | 1.02% | -30.77% | -14.70% | 4.97% | -4.21% |
| Net Income Per EBT | 132.53% | 121.19% | 61.08% | 107.90% | 64.91% |
| EBT Per EBIT | 7.67% | 109.92% | 131.04% | 58.73% | 141.79% |
| Return on Assets (ROA) | 0.77% | -17.87% | -9.43% | 3.43% | -3.02% |
| Return on Equity (ROE) | 1.69% | -46.29% | -21.50% | 7.27% | -6.36% |
| Return on Capital Employed (ROCE) | 15.78% | -29.41% | -23.10% | 8.96% | -4.34% |
| Return on Invested Capital (ROIC) | 12.12% | -20.88% | -9.89% | 7.43% | -2.60% |
| Return on Tangible Assets | 1.09% | -23.43% | -12.73% | 4.49% | -4.18% |
| Earnings Yield | 0.55% | -21.91% | -10.20% | 2.56% | -0.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.53 | 1.39 | 2.16 | 1.99 | 1.51 |
| Payables Turnover | 1.91 | 2.49 | 0.91 | -1.10 | -0.72 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 18.25 | 12.22 | 11.06 | 12.29 | 31.18 |
| Asset Turnover | 0.75 | 0.58 | 0.64 | 0.69 | 0.72 |
| Working Capital Turnover Ratio | 14.16 | -46.42 | -342.18 | 4.90 | 1.85 |
| Cash Conversion Cycle | 47.63 | 116.77 | -233.51 | 514.34 | 751.53 |
| Days of Sales Outstanding | 238.66 | 263.32 | 168.83 | 183.47 | 242.22 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 191.02 | 146.55 | 402.33 | -330.86 | -509.31 |
| Operating Cycle | 238.66 | 263.32 | 168.83 | 183.47 | 242.22 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.28 | 0.03 | 0.04 | -0.34 | -0.24 |
| Free Cash Flow Per Share | -0.05 | -0.19 | -0.03 | -0.46 | -0.41 |
| Dividend Paid and CapEx Coverage Ratio | 0.84 | 0.14 | 0.56 | -2.82 | -1.41 |
| Capital Expenditure Coverage Ratio | 0.84 | 0.14 | 0.56 | -2.82 | -1.41 |
| Operating Cash Flow Coverage Ratio | 1.02 | 0.07 | 0.07 | -0.74 | -0.58 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.03 | 0.03 | -0.26 | -0.27 |
| Free Cash Flow Yield | -2.12% | -11.16% | -1.57% | -18.25% | -10.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 182.01 | -4.51 | -9.81 | 39.03 | -106.60 |
| Price-to-Sales (P/S) Ratio | 1.86 | 1.40 | 1.44 | 1.94 | 4.49 |
| Price-to-Book (P/B) Ratio | 3.07 | 2.11 | 2.11 | 2.84 | 6.78 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -47.10 | -8.96 | -63.59 | -5.48 | -9.59 |
| Price-to-Operating Cash Flow Ratio | 9.12 | 55.98 | 49.53 | -7.42 | -16.38 |
| Price-to-Earnings Growth (PEG) Ratio | -1.75 | -0.05 | 0.02 | -0.14 | 1.49 |
| Enterprise Value Multiple | 9.16 | -205.37 | -10.99 | 14.89 | 77.85 |
| Enterprise Value | 72.30M | 45.21M | 52.49M | 49.13M | 63.93M |
| EV to EBITDA | 9.16 | -205.37 | -10.99 | 14.89 | 77.85 |
| EV to Sales | 2.01 | 1.57 | 1.79 | 2.20 | 4.86 |
| EV to Free Cash Flow | -50.84 | -9.99 | -78.98 | -6.23 | -10.39 |
| EV to Operating Cash Flow | 9.85 | 62.41 | 61.52 | -8.44 | -17.74 |
| Tangible Book Value Per Share | 0.29 | 0.30 | 0.39 | 0.44 | 0.24 |
| Shareholders’ Equity Per Share | 0.82 | 0.79 | 0.95 | 0.88 | 0.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.33 | -0.21 | 0.39 | -0.08 | 0.35 |
| Revenue Per Share | 1.36 | 1.19 | 1.39 | 1.29 | 0.88 |
| Net Income Per Share | 0.01 | -0.37 | -0.20 | 0.06 | -0.04 |
| Tax Burden | 1.33 | 1.21 | 0.61 | 1.08 | 0.65 |
| Interest Burden | 0.25 | 1.26 | 1.30 | 0.77 | 1.84 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.25 | 0.35 | 0.24 | 0.22 | 0.30 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 26.40 | -0.10 | -0.20 | -5.67 | 4.22 |
Currency in EUR
